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Abstract
A low-protein diet leads to functional and structural pancreatic islet alterations, including islet hypotrophy. Insulin-signaling 
pathways are involved in several adaptive responses by pancreatic islets. We determined the levels of some insulin-signaling 
proteins related to pancreatic islet function and growth in malnourished rats. Adult male Wistar rats (N = 20 per group) were 
fed a 17% protein (normal-protein diet; NP) or 6% protein (low-protein diet; LP), for 8 weeks. At the end of this period, blood 
glucose and serum insulin and albumin levels were measured. The morphometric parameters of the endocrine pancreas and 
the content of some proteins in islet lysates were determined. The β-cell mass was significantly reduced (≅65%) in normoglyce-
mic but hypoinsulinemic LP rats compared to NP rats. Associated with these alterations, a significant 30% reduction in insulin 
receptor substrate-1 and a 70% increase in insulin receptor substrate-2 protein content were observed in LP islets compared 
to NP islets. The phosphorylated serine-threonine protein kinase (pAkt)/Akt protein ratio was similar in LP and NP islets. The 
phosphorylated forkhead-O1 (pFoxO1)/FoxO1 protein ratio was decreased by 43% in LP islets compared to NP islets (P < 
0.05). Finally, the ratio of phosphorylated-extracellular signal-related kinase 1/2 (pErk1/2) to total Erk1/2 protein levels was 
decreased by 71% in LP islets compared to NP islets (P < 0.05). Therefore, the reduced β-cell mass observed in LP rats is 
associated with the reduction of phosphorylation in mitogenic-related signals, FoxO1 and Erk proteins. The cause/effect basis 
of this association remains to be determined.
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Malnourishment induces functional and structural 
alterations in the endocrine pancreas in fetal, neonatal 
(1-4) and adult rats (5-9). We have shown that malnutrition 
caused by a low-protein diet increases insulin sensitivity 
in peripheral tissues of adult rats (6,7). Malnourished rats 
exhibit reduced levels of circulating insulin that may be a 
consequence of decreased islet responsiveness to glucose 
(5-7). Reduction of islet size is also observed in these rats 
(6,9). Other studies have reported alterations in pancreatic 
islet structure in models of undernutrition. Among these 
alterations, reduction in β-cell mass and proliferation has 
been reported, as well as diminished islet vasculariza-
tion (1-4). Changes in peripheral insulin sensitivity are 
compensated by reciprocal alterations in islet mass and 
function (10-13). The interaction between the systemic 
requirement for insulin and islet function guarantees that 
blood glucose is kept within physiological ranges in rats 
when malnutrition is induced by a low-protein diet (6,7). 
The adaptive modifications in the endocrine pancreas 
are commonly associated with alterations in the status of 
the insulin-signaling pathway. Insulin exerts its biological 
effects by binding to its insulin receptor, which is a hetero-
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tetrametric protein with tyrosine kinase activity (14,15). 
The insulin receptor substrates-1 (Irs-1) and -2 (Irs-2) are 
high-molecular weight proteins that are phosphorylated 
at several tyrosine residues by activated insulin receptor 
protein. These substrates connect to the proteins containing 
homology domains to Scr2 (SH2), such as the regulatory 
subunit p85 of phosphatidylinositol 3-kinase (Pi3-k) (16) 
and adapting proteins such as Grb-2/Sos and Shp-2 (17). 
The activation of Pi3-k and Grb-2/Sos triggers the signaling 
cascade of mitogen-activated protein kinase (MAPK) and the 
sequential activation of the proto-oncogenes Ras and Raf, 
leading to extracellular-signal regulated kinase-1 (Erk1) and 
-2 (Erk2) activation. The activation of the insulin-signaling 
pathway is involved in the regulation of cell differentiation, 
growth and survival (18). 
Reports correlating malnutrition and the insulin pathway 
during islet compensatory mechanisms are scarce. Here 
we report the determination of some crucial components of 
the insulin cascade in a model of hypotrophied pancreatic 
islets induced by a low-protein diet.
Material and Methods
Material 
Collagenase, bovine serum albumin (fraction V), imi-
dazole, ethylene diamine tetraacetic acid, ethylene glycol 
tetraacetic acid, pepstatin, aprotinin, phenylmethylsulfonyl 
fluoride, leupeptin, trypsin inhibitor, and Triton X-100 were 
from Sigma (USA). Western blotting was performed using 
the Bio-Rad system (USA). All reagents for Western blot-
ting were from Sigma or Bio-Rad. Antibodies against the β 
subunit of the insulin receptor (IR-β; SC-711), Irs-1 (SC-560) 
and Irs-2 (SC-9299), serine-threonine protein kinase (Akt; 
SC-8312), phosphorylated Akt (pAkt; SC-7985, Ser473), 
Erk1/2 (SC-93), phosphorylated Erk1/2 (pErk1/2; SC-7383), 
and α-tubulin (SC-8035) were obtained from Santa Cruz 
Biotechnology (USA). Antibodies against forkhead-O1 
(FoxO1; #2488) and phosphorylated forkhead-O1 (pFoxO1; 
#2486) were from Cell Signaling Technology (USA). The 
antibody against pancreas duodenum homeobox-1 (Pdx-
1) (AB3243) was obtained from Chemicon International, 
Inc. (USA).
Animals and diet 
Male Wistar rats (21 days of age) from the Universi-
dade Estadual de Campinas Animal Breeding Center were 
maintained at 24°C on a 12-h light/dark cycle. A total of 40 
rats were divided randomly into 2 groups (20 per group) 
respectively fed an isocaloric diet containing 6% protein 
(low-protein diet, LP group) or 17% protein (control diet, 
NP group) for 8 weeks. The compositions and differences 
between diets (6) are described in Table 1. Both diets are 
isocaloric containing 3.76 kcal/g. During the experimental 
period, the rats had free access to food and water. The 
experiments reported here were approved by the Comis-
são de Ética na Experimentação Animal (CEEA), Instituto 
de Biologia, UNICAMP.
Metabolic, hormonal and biochemical determinations
On the day after the 8-week treatment, fasted rats 
(12-14 h) were sacrificed by CO2 exposure, followed by 
decapitation. Before sacrifice, blood glucose concentra-
tion was measured from the tip tail using a glucosimeter 
(One Touch, Johnson & Johnson, USA). Serum samples 
obtained after centrifugation of trunk blood were used for 
later measurement of insulin levels by radioimmunoassay. 
The 125I-labeled insulin (human recombinant) for radioim-
munoassay was purchased from Amersham Biosciences 
(UK). Serum albumin levels was also quantified according 
to manufacturer instructions (In Vitro Diagnostica, Brazil) by 
spectrophotometry (Spectronic® 20 Genesys™, Spectronic 
Unicam, USA).  
Isolation of pancreatic islets 
A separate group of fed rats was used for the isolation 
of pancreatic islets by the collagenase method. Briefly, the 
pancreas was inflated with Hanks’ solution containing 0.8 
mg/mL collagenase, and then removed from the rat and kept 
at 37°C for 23 min. After tissue digestion, the islets were 
collected manually under a microscope using a siliconized 
Pasteur pipette and randomly divided into two pools, one 
for the measurement of islet area “en bloc” and the other 
for Western blotting experiments. 
Islet area, β-cell mass and Pdx-1 cellular distribution
Islet area was measured as previously described (6,19). 
To study β-cell mass and cellular distribution of Pdx-1, the 
endocrine pancreas was excised from 4 animals in each 
group and processed as previously described (19-21). The 
relative and absolute β-cell mass as well as the islet number 
per pancreatic area were determined by point-counting 
morphometry on each pancreas section immunostained for 
Table 1. Composition of the control (17% protein) and low-protein 
(6% protein) isocaloric diets. 
Ingredient Control diet 
(g/kg)
Low-protein 
diet (g/kg) 
Casein (84% protein) 202.0 71.5
Cornstarch 397.0 480.0
Dextrinized cornstarch 130.5 159.0
Sucrose 100.0 121.0
Soybean oil 70.0 70.0
Fiber 50.0 50.0
Mineral mix (AIN-93G) 35.0 35.0
Vitamin mix (AIN-93G) 10.0 10.0
L-cystine 3.0 1.0
Choline hydrochloride 2.5 2.5
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insulin as previously reported (20,21). A minimum of 500 
fields per pancreas were counted. Cell distribution of Pdx-1 
was analyzed in sections immunostained for Pdx-1 (21). 
Tissue extraction and immunoblotting
Islet protein (100 µg) was used for each experiment as 
previously reported (20,21). Immunoblotting experiments 
were performed at least five times. Briefly, the proteins were 
transferred to a nitrocellulose membrane and checked for 
transfer efficiency staining with Ponceau S at the end of 
transfer. The membranes were then blocked with TBST (10 
mM Trizma base, 150 mM NaCl, 0.05% Tween 20) plus 5% 
dried skim milk for 2 h, washed in TBST (3 x 5 min) and 
incubated overnight with the appropriate primary antibody 
at room temperature in TBST plus 3% dry skim milk. After 
washing in TBST (3 x 5 min), membranes were incubated 
with the appropriate secondary antibody conjugated with 
HRP for 2 h in TBST plus 1% dried skim milk at room 
temperature. Antibody binding was detected using the 
enhanced SuperSignal® West Pico Chemiluminescent Sub-
strate (Pierce, USA), as described by the manufacturer. Blots 
were scanned (Epson expression 1600) and densitometry 
of the protein bands was determined by pixel intensity using 
the Scion Image software (Scion Corporation, USA).
Statistical analysis 
All numerical results are reported as means ± SEM of 
the indicated number (N) of experiments. The Student t-test 
for unpaired groups was used for comparison between NP 
and LP data, with the level of significance set at P < 0.05. 
Results
Body weight, blood glucose and serum albumin and 
insulin levels
As stated in Ref. 6, LP rats had a significantly reduced 
body weight (210 ± 1.8 vs 406 ± 12 g for LP and NP, respec-
tively) and a significant decrease in fasting serum albumin 
and insulin levels compared to the NP rats (N = 10, P < 
0.05). The values for NP and LP were 3.6 ± 0.02 and 3.18 
± 0.06 g/dL for albumin and 0.49 ± 0.01 and 0.26 ± 0.02 
ng/mL for serum insulin levels, respectively. The fasting 
glucose levels were similar in both NP and LP rats (67.1 ± 
4.3 and 62.2 ± 3.5 mg/dL, respectively). 
Reduced pancreatic islet area and β-cell mass in 
pancreas from LP rats
The morphometric parameters revealed differences 
between LP and NP pancreatic islets. The islet area was 
significantly reduced in LP compared to NP rats (7390 ± 
230 vs 15,370 ± 450 µm2, respectively; N = 400 islets, 
pooled from 3 rats; P < 0.001). Sections stained for insulin 
exhibited the pattern of islet size and number in NP and 
LP rat pancreas (Figure 1A,B). Islets from LP rats seem 
to be smaller in size compared to those observed in NP 
rats (compare islets indicated by arrows in Figure 1A and 
Figure 1. Islet morphometry parameters. Represen-
tative images of a pancreas section stained for in-
sulin and hematoxylin showing the pattern of islets 
distribution (A,B). Scale bars = 500 µm. Observe 
that islets from low-protein diet (LP) rats seem to be 
smaller in size compared to those observed in nor-
mal-protein diet (NP) rats (compare islets indicated 
by arrows in Figure 1A and B). Absolute β-cell mass 
(pancreatic weight multiplied by relative β-cell mass) 
was significantly reduced in rats receiving an LP diet 
(C). Data are reported as means ± SEM. *P < 0.05 
compared to NP (N = 4; Student t-test).
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B). The total pancreas weight was significantly reduced in LP 
compared to NP rats (0.46 ± 0.04 vs 1.35 ± 0.03 g, respectively; 
N = 4, P < 0.05). Morphometric analysis revealed that the rela-
tive β-cell mass was similar in the two groups (1.26 ± 0.07 vs 
1.18 ± 0.03%, respectively). However, a marked reduction in 
absolute β-cell mass was observed in LP compared to NP rats 
after correction for pancreas weight (0.55 ± 0.05 vs 1.69 ± 0.08 
mg, respectively; P < 0.05, N = 4; Figure 1C). Since LP rats had 
a reduced body weight, we next normalized the β-cell mass 
to body weight and observed a reduction in β-cell mass/body 
weight of LP compared to NP rats (0.26 ± 0.02 vs 0.42 ± 0.02 
mg/100 g, respectively; P < 0.05). Finally, the number of islets 
per pancreatic area was similar in NP and LP rats (1.17 ± 0.06 
vs 1.53 ± 0.21 islet number/per pancreas area, respectively. 
IR-β, Irs-1, and Irs-2 protein content in LP islets
Western blotting experiments were performed to de-
termine whether altered islet size was associated with 
any modification in insulin receptor and insulin receptor 
substrate proteins. Figure 2A shows a significant 2.7-fold 
Figure 2. Protein content of A, insulin receptor β (IR-β); B, insulin receptor substrate-1 (Irs-1), and C, insulin receptor substrate-2 
(Irs-2) in pancreatic islets from rats receiving a normal-protein diet (NP) and a low-protein diet (LP). A representative control blot for 
α-tubulin is shown below each panel. Data are reported as means ± SEM for 5 independent experiments. *P < 0.05 compared to NP 
(Student t-test).
Figure 3. Protein ratio of A, phosphorylated serine-threonine protein kinase (pAkt)/Akt, of B, phosphorylated forkhead-O1 (pFoxO1)/
FoxO1, and of C, phosphorylated extracellular signal-regulated kinase 1/2 (pErk1/2)/Erk1/2 in pancreatic islets from rats receiving a 
normal-protein diet (NP) and a low-protein diet (LP). A representative control blot for α-tubulin is shown below each panel. Data are 
reported as means ± SEM for 5 independent experiments. *P < 0.05 compared to NP (Student t-test).
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increase in the β subunit content 
of insulin receptor protein in islets 
from LP compared to NP rats (P < 
0.05). However, the level of Irs-1 
protein was significantly lower (30%) 
in islets from LP rats than in islets 
from NP rats (P < 0.05; Figure 2B). 
In contrast, Irs-2 protein content was 
significantly increased by 1.7-fold in 
islets from LP rats compared to NP 
rats (P < 0.05; Figure 2C). 
Phosphorylation and total 
levels of Akt, FoxO1 and Erk1/2 
proteins in LP islets 
Since the protein phosphoryla-
tion status suggests the degree of 
activity of a protein, we investigated 
the levels of protein phosphorylation 
and total content of some important 
proteins involved in islet growth. To-
tal Akt protein content and pAkt were 
not different in LP islets compared 
to NP. The pAkt/Akt protein ratio in 
islet lysates was similar for the two 
groups (Figure 3A). The analysis of 
total FoxO1 protein content revealed 
similar quantities of protein in NP and 
LP islets (Figure 3B). However, the 
pFoxO1 protein levels decreased 
significantly in LP islets compared 
to NP (P < 0.05). Thus, an important 
reduction of 43% in the pFoxO1/
FoxO1 ratio was observed in islets 
from LP rats compared to NP rats 
(P < 0.05; Figure 3B). The protein 
levels of total Erk1/2 were similar for 
NP and LP islets (Figure 3C). This 
pattern was not observed when the 
phosphorylated levels of Erk1/2 protein were determined. 
Rats submitted to a low-protein diet exhibited a significant 
reduction in pErk1/2 protein levels when compared to NP 
islets (P < 0.05; Figure 3C). Accordingly, a decrease of 71% 
in the pErk1/2/Erk1/2 ratio was observed in LP compared 
to NP rats (P < 0.05; Figure 3C).
Levels of Pdx-1 protein in islet lysates and cellular 
distribution in pancreatic islets from LP rats 
To confirm whether any alteration in Pdx-1 protein 
content in islets from LP rats may be associated with islet 
hypotrophy, we determined the levels of this protein. Figure 
4A shows similar levels of Pdx-1 protein in both NP and 
LP islet lysates. Qualitative analysis of Pdx-1 in pancreas 
sections confirmed the wide distribution of this protein in 
pancreatic β-cell nuclei and cytoplasm in both groups (Figure 
4B,C). No apparent differences were noted regarding the 
cytoplasmic versus nuclear localization of Pdx-1 in LP and 
NP rats (Figure 4D,E). 
Discussion
In this study, we showed for the first time an association 
between reduced β-cell mass and decreased phosphoryla-
tion levels of FoxO1 and Erk1/2 proteins in pancreatic islets 
of malnourished rats receiving a low-protein diet. 
Our data also confirm previous studies (8,9) showing 
that rats submitted to a low-protein diet exhibit reduced 
β-cell mass (Figure 1C). An increase in the population 
of small islets and a decrease in the population of large 
islets were observed by Tse et al. (9), as also observed in 
the present study. Smaller islets can be easily observed in 
Figure 4. Protein content of pancreatic-duodenal homeobox 1 (Pdx-1) in pancreatic islets 
from rats receiving a normal-protein diet (NP) and a low-protein diet (LP) (A). A representa-
tive control blot for α-tubulin is shown on the right side of panel A. The bars are means ± 
SEM for 5 independent experiments. *P < 0.05 compared to NP (Student t-test). Panels B 
and C show representative images of pancreatic sections stained for Pdx-1 and hematoxy-
lin, showing the wide distribution of Pdx-1 in pancreatic islets from both groups. Note the 
similar Pdx-1 protein distribution in NP and LP islets (D, E). Scale bars = 100 µm for B, C 
and 45 µm for D, E.
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pancreas sections from LP rats (Figure 1B), which were 
in agreement with the reduced mean islet size. Since the 
body weight of LP rats was also reduced, we normalized 
the absolute β-cell mass according to whole body weight. 
The normalized β-cell mass also indicated a reduced β-cell 
mass in LP compared to NP rats. Based on these results, 
we suggest that the hypoinsulinemia observed in LP rats 
is not attributable solely to decreased islet function (5-7), 
but rather that the reduced β-cell mass can negatively af-
fect this process. 
The insulin and insulin-like growth factor signaling 
pathways play an important role in the control of β-cell 
growth and of insulin biosynthesis and secretion (22-24). 
Analysis of the initial components of the insulin signaling 
pathway revealed an increase in the expression of IR-β in 
LP islets compared to NP islets (Figure 2A). Irs-1 protein 
levels were consistently diminished, whereas Irs-2 was 
augmented in LP islets compared to NP islets (Figure 2B,C). 
Modulation of islet functions, such as insulin secretion, 
involves the participation of Irs-1 protein. Overexpression 
of Irs-1 in rat insulinoma cells results in increased glucose-
stimulated insulin secretion (25). However, Irs-1-/- mice 
present decreased glucose-stimulated insulin secretion and 
reduced islet insulin content (26), but also demonstrate a 
compensatory increase in Irs-2 protein in pancreatic islets, 
leading to islet hyperplasia (23,27). In contrast to Irs-1, 
Irs-2 seems to participate mainly in the control of β-cell 
growth. Irs-2 knock-out mice show islet hypoplasia (28), 
while overexpression of this protein in pancreatic β-cells 
results in β-cell proliferation (29). The diminished levels of 
Irs-1 protein in LP islets support the reduced levels in insulin 
release, as judged by the circulating insulin levels in these 
rats. The increase in Irs-2 protein content observed in LP 
islets may be an adaptive mechanism compensating for 
the Irs-1 reduction. Although the increase in Irs-2 levels, 
accompanied by a decrease in islet size, is intriguing, this 
could be explained by a modification in downstream signal-
ing intermediates.
The Pi3-k cascade involves the activation of several pro-
teins including the serine-threonine protein kinase Akt. Akt 
has been shown to be important for glucose homeostasis, 
growth and cell survival (30,31). However, the similar levels 
of phosphorylated Akt and total Akt (Figure 3A) suggest 
that this kinase does not participate in the reduced islet 
size observed here in LP rats.
The forkhead family of the transcription factor FoxO1 
plays an important role in the regulation of cell proliferation, 
apoptosis and senescence (32). Growth factors and insulin 
pathway components negatively regulate the activity of 
FoxO1 (32). The activated protein kinases, Pi3-k and Akt, 
may phosphorylate FoxO1 protein. When phosphorylated, 
FoxO1 becomes inactive and moves from the nucleus to 
the cytoplasm (32). Inside the nucleus, FoxO1 appears 
to be a repressor of Pdx-1 expression (33) and prevents 
β-cell hyperplasia (34). The decreased phosphorylation of 
FoxO1 protein in islets from LP rats (Figure 3B) can exert 
a negative effect on β-cell proliferation, in agreement with 
the islet hypotrophy observed in these malnourished rats. 
As mentioned above, the active form (non-phosphorylated) 
of FoxO1 protein may repress Pdx-1 expression (32,33); 
however, we did not detect any significant modification in 
Pdx-1 distribution in pancreatic islet cells nor any differ-
ences in Pdx-1 protein expression in LP compared to NP 
rats (Figure 4A,B). Other signals such as the FoxA2 tran-
scription factor (35), and the transforming growth factor-β 
and IkB/NFk-B (32) could be involved in the modulation 
of Pdx-1 or FoxO1 activity, respectively. Thus, the com-
pensatory decrease in the islet area of LP rats seems 
not to be preferentially mediated by reductions in Akt and 
Pdx-1 expression. However, we cannot rule out FoxO1 as 
an important end signaling molecule that could force the 
hypoplasia of β-cells in LP islets.
We also showed that LP rats exhibited a reduction in 
phosphorylated Erk1/2 levels in islet lysates (Figure 2C). 
The MAPK pathway is stimulated by mitogenic factors 
and its importance in cell proliferation and differentiation 
has been well documented (36,37). After activation of the 
insulin receptor, there is an interaction and subsequent 
phosphorylation of the tyrosine residues of the Shc protein. 
Once phosphorylated, Shc recruits Grb-2 and activates the 
Sos-Ras-c-Raf-Mek1/2-Erk pathway (38-40). The reduced 
phosphorylated state of the Erk1/2 protein supports the 
decrease in islet area observed in LP rats. Since insulin 
may act as a positive signal for the activation of the MAPK 
pathway, the lower levels of circulating insulin observed 
in LP rats may exert less influence on MAPK activation. 
Furthermore, neonatal rats from dams receiving a low-
protein diet during pregnancy show reduced insulin-like 
growth factor-2 mRNA and protein levels in pancreatic islet 
cells (3), supporting the reduced Erk activity observed in 
the pancreatic islets of LP rats. This, in turn, reinforces the 
hypotrophy of the pancreatic islets of these rats. 
Based on these results, we conclude that reduced 
levels of FoxO1 and Erk1/2 protein phosphorylation in 
pancreatic islets can negatively regulate β-cell growth, 
leading to islet hypotrophy and reduced β-cell mass in 
malnourished rats. 
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